文献速递细胞病理与分子病理

细胞病理学质量项目中修订报告监测的价值:一项双年度回顾

The value of monitoring amended reports in cytopathology quality programs: A biennial review.
PubMed 文献 · Cancer Cytopathol · 2022-06-06

该研究回顾了大型细胞病理实验室2年内所有修订报告,共202份,修订率为0.275%。妇科病例以一般报告缺陷为主(68.7%),非妇科病例以诊断错误为主(62.2%),其中32例为真实诊断改变。研究认为修订报告是未被充分认识的有价值质量保证工具。

要点

  • 细胞病理修订报告率为0.275%,非妇科病例诊断错误占比更高。
  • 妇科病例中一般报告缺陷占68.7%,是主要错误类型。
  • 修订报告分析可揭示错误类型并指导质量改进。

核心结论

  • 研究修订报告是细胞病理学中未被充分认识且有价值的质量保证工具。
  • 修订报告有助于提供错误类型信息、监测实验室流程并指导质量改进。

研究设计与样本

  • 回顾性研究纳入2019年7月至2021年6月2年期间所有修订报告。
  • 修订报告按根本原因分为标本标识错误、一般报告缺陷和诊断错误三类。

主要发现

  • 共发出202份修订报告,修订率为0.275%。
  • 妇科病例83例(41.1%),非妇科病例119例(58.9%)。
  • 妇科病例中标本标识错误13例(15.7%)、诊断错误13例(15.7%)、一般报告缺陷57例(68.7%)。
  • 非妇科病例中标本标识错误15例(12.6%)、一般报告缺陷30例(25.2%)、诊断错误74例(62.2%),其中32例为真实诊断改变。
  • 发现方法包括提供额外临床信息后复审、额外辅助检测后重新解释或会议审查,与执业年限无相关性。

临床怎么用

  • 建议细胞病理实验室将修订报告监测纳入质量保证项目。
  • 通过分析修订报告的错误类型和根本原因,针对性改进实验室流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quality and safety are the foundation of the practice of cytopathology. Review of key performance indicator (KPI) data can shine a light on laboratory vulnerabilities and potential areas for targeted improvement. The rate and content of amendment reports is a frequently monitored KPI in anatomic pathology, but few have studied its value in cytopathology. The goal of this study was to examine the frequency, classification, and outcome of amendments for a large cytopathology laboratory. METHODS: All amendment reports issued for cases during a 2-year period from July 2019 to June 2021 were included in the study. Amendments were classified into three error type root causes: Specimen Identification Error, General Report Defects, and Diagnostic Error. RESULTS: A total of 202 amendment reports were issued equating to a rate of 0.275%. A total of 83 (41.1%) were gynecologic cases and 119 (58.9%) were nongynecologic cases. Within the gynecologic cases, 13 (15.7%) cases were due to Specimen Identification Error, 13 (15.7%) cases were due to Diagnostic Error, and 57 (68.7%) cases were due to General Report Defects. Within the nongynecologic cases, 15 (12.6%) cases were due to Specimen Identification Error, 30 (25.2%) cases were due to General Report Defects, and 74 (62.2%) cases were due to Diagnostic Error with 32 of these due to true diagnostic change. Discovery methods included following re-review after additional clinical information was provided, reinterpretation after additional ancillary testing was performed, or conference review. There was no correlation with years in practice. CONCLUSIONS: Studying amendment reports is an underrecognized and valuable quality assurance tool. Amendments can help provide information about types of errors, monitor laboratory processes, and help guide quality improvement endeavors.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Torous VF, Pitman MB, Heher YK, et al. The value of monitoring amended reports in cytopathology quality programs: A biennial review. Cancer Cytopathol. 2022. PMID: 35666141. doi:10.1002/cncy.22607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。